Disease Info Card

Elliptocytosis, Hereditary

Information about Elliptocytosis, Hereditary: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Elliptocytosis, Hereditary

Most recent studies have shown that Elliptocytosis, Hereditary shares some biological mechanisms with acidosis, anemia, anemia-hemolytic, anemia-hemolytic-congenital, anemia-sickle-cell, beta-thalassemia, cell-invasion, glucosephosphate-dehydrogenase-deficiency, hematological-disease, hemoglobinopathies, hemolysis-(disorder), hereditary-pyropoikilocytosis, hereditary-spherocytosis, icterus, malaria, malaria-falciparum, renal-tubular-acidosis, renal-tubular-acidosis-type-i, stomatocytic-anemia, thalassemia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Elliptocytosis, Hereditary, and have been seen in publications frequently: Acid Secretion, Aging, Anion Transport, Cell Adhesion, Coagulation, Diapedesis, Enucleation, Excretion, Localization, Membrane Budding, Membrane Organization, Mrna Processing, Mrna Splicing, Pathogenesis, Proteolysis, Rna Splicing, Secretion, Translation, Transport, Transposition

Quite a number of genes have been found to play important roles in Elliptocytosis, Hereditary, such as ACSL4, ANK1, EPB41, EPB41L1, G6PD, GYPC, MAP3K14, RHCE, RHD, SLC4A1, SPTA1, SPTB, TFF2, UBL4A. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.